Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Clinical trial NCT01202565 · COMPLETED

Trial details

NCT number: NCT01202565
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Study type: OBSERVATIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2010-09-01
Primary completion: 2013-07-01
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.